FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Jakeman David

2. Date of Event Requiring Statement (MM/DD/YYYY)
6/20/2019 

3. Issuer Name and Ticker or Trading Symbol

CHIMERIX INC [CMRX]

(Last)        (First)        (Middle)

C/O CHIMERIX, INC., 2505 MERIDIAN PARKWAY, SUITE 100

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Principal Accounting Officer /

(Street)

DURHAM, NC 27713       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   20006   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)     (2) 4/7/2021   Common Stock   5250   $2.35   D    
Stock Option (Right to Buy)     (2) 1/28/2024   Common Stock   6000   $18.75   D    
Stock Option (Right to Buy)     (2) 1/28/2025   Common Stock   6000   $39.41   D    
Stock Option (Right to Buy)   1/8/2016   (3) 1/8/2026   Common Stock   10150   $8.06   D    
Stock Option (Right to Buy)   8/1/2016   (3) 8/1/2026   Common Stock   10000   $4.08   D    
Stock Option (Right to Buy)   1/25/2018   (3) 1/25/2028   Common Stock   7200   $4.68   D    
Stock Option (Right to Buy)   12/12/2018   (4) 12/12/2028   Common Stock   1250   $3.39   D    
Stock Option (Right to Buy)   1/23/2019   (3) 1/23/2029   Common Stock   9360   $2.41   D    

Explanation of Responses:
(1)  Amount includes (i) 7,375 unvested shares pursuant to a restricted stock unit award issued on January 24, 2017, (ii) 2,700 unvested shares pursuant to a restricted stock unit award issued on January 25, 2018 and (iii) 4,680 unvested shares pursuant to a restricted stock unit award issued on January 23, 2019.
(2)  Fully vested and exercisable.
(3)  1/48th of the shares will vest each month over a four year period following the vesting commencement date identified in column 2 above.
(4)  Fully vested and exercisable on date of grant identified in column 2 above.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Jakeman David
C/O CHIMERIX, INC.
2505 MERIDIAN PARKWAY, SUITE 100
DURHAM, NC 27713

Principal Accounting Officer

Signatures
/s/ Michael Alrutz, Attorney-in-Fact 6/24/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Chimerix Charts.
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Chimerix Charts.